Table 3.
Henoch–Schonlein purpura (HSP): Serum levels of advanced oxidation protein products (AOPPs) in different subgroups of HSP patients and controls
| Subgroup | Sample size | AOPPs (μmol/L) (MD(IQR)) |
|---|---|---|
| Skin subgroup | 20 | 37.585 (28.99)a, b |
| Joint subgroup | 8 | 68.610 (67.70)a, b, c |
| Abdominal subgroup | 12 | 65.710 (34.19)a, b, c |
| Renal subgroup | 114 | 121.750 (139.49)a, c |
| Controls | 18 | 13.890 (25.09) |
| After square root conversion | F = 23.068 | |
| Single‐factor ANOVA | P = 0.000 | |
a
Significantly higher compared with control group P < 0.01.
b
Significantly lower compared with renal‐type subgroup P < 0.01.
c
Significantly higher compared with skin‐type subgroup P < 0.01.